African American Children, Glycemic Control, and Type 2 Diabetes
Completed · Not applicable · Has a placebo group
Conditions studied: Type 2 Diabetes, Vitamin D Deficiency
In brief
Using a randomized, placebo-controlled trial design in subjects with vitamin D deficiency, the investigators propose to determine if vitamin D treatment improves glycemic control in vitamin D deficient subjects with T2DM. The investigators hypothesize that oral vitamin D treatment will improve glycemic control and ß-cell function in vitamin D deficient AA subjects with T2DM. The investigators further hypothesize that maintaining serum 25(OH)D concentrations above 20 ng/ml with oral supplementation of vitamin D will have additional glycemic control effects.
Key facts
- Study ID
- NCT01325987
- Run by
- University of Alabama at Birmingham
- People needed
- 31
- Starts
- 2011-03-01
- Expected to finish
- 2013-06-01
- Last updated by the study team
- 2014-01-20
Who can join
Age: 12 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Type 2 DM with acanthosis
- African American
- 12-18 years
- BMI> 85%
- Tanner Stage > 4
You may not qualify if…
- Those taking vitamin D
- Pregnancy
- Those with chronic health conditions other than diabetes
- Those who are deemed medically unstable to participate in research
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.